Prostate cancer drug that can halve death risk to be offered to thousands in England
At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects Thousands of men with advanced prostate cancer in England are to be offered a drug that can halve the risk of death. In guidance published on Friday, the National (…)
Site référencé:
The Guardian (South&CentralAsia)
3333.jpg?width=140&quality=85&auto=format&fit=max&s=4ef98f38f4c778416f19eff8a360aecc, 3333.jpg?width=460&quality=85&auto=format&fit=max&s=1150db78d91fedf560db661d7de6d353, 3333.jpg?width=700&quality=85&auto=format&fit=max&s=b88b50e1202d2797417341d7e43a97ab
The Guardian (South&CentralAsia)
Diversity in architecture has taken a backwards step | Letter
23/10/2025
Up pops Katie Lam to outdo Robert Jenrick on the nastiness scale | John Crace
23/10/2025
Asda hires autistic man who was let go by Waitrose after years of volunteering
23/10/2025
Dave Ball was not some bloke in the background of Soft Cell – he drove their startling, subversive sound
23/10/2025
Woman tells spycops inquiry of ‘deep mistrust’ of police after relationship with undercover officer
23/10/2025
‘TV hits don’t run for ever’ : are Tess Daly and Claudia Winkleman leaving Strictly because it’s about to be axed ?
23/10/2025